[Molecular biology and new drug therapy for myeloproliferative neoplasm].
Akira
A
Kitanaka
Kotaro
K
Shide
Kazuya
K
Shimoda
D000818:Animals; D019046:Bone Marrow Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D004268:DNA-Binding Proteins / Q000235:genetics; D049308:Dioxygenases; D020022:Genetic Predisposition to Disease; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors / Q000235:genetics; D009154:Mutation / Q000235:genetics; D009196:Myeloproliferative Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics
D004268:DNA-Binding Proteins; D011518:Proto-Oncogene Proteins; D049308:Dioxygenases; C541081:TET2 protein, human; D053614:Janus Kinase 2